Suppression of epithelial signal transducer and activator of transcription 1 activation by extracts of Aspergillus fumigatus

American Journal of Respiratory Cell and Molecular Biology

Volumn 53, Issue 1, 2015, Pages 87-95

  Bhushan, Bharat ^a   Homma, Tetsuya ^a   Norton, James E ^b   Sha, Quan ^a   Siebert, Jason ^c   Gupta, Dave S ^d   Schroeder, James W ^e   Schleimer, Robert P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e DEPARTMENT OF MEDICINE   (United States)

Author keywords

Aspergillus fumigatus; BAFF; Epithelial cells; IP 10

Indexed keywords

B CELL ACTIVATING FACTOR; BETA INTERFERON; DOUBLE STRANDED RNA; FUNGAL EXTRACT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3; AUTACOID; CYTOKINE; DRUG MIXTURE; MESSENGER RNA; STAT1 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHIAL EPITHELIAL CELL; BRONCHUS MUCOSA; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; EPITHELIUM CELL; HUMAN; MOLECULAR SIZE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TH1 CELL; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DOWN REGULATION; DRUG EFFECTS; DRUG MIXTURE; GENETICS; LUNG ASPERGILLOSIS; METABOLISM; PATHOLOGY; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; TOXICITY;

ASPERGILLUS FUMIGATUS;

ASPERGILLUS FUMIGATUS; CELL LINE; COMPLEX MIXTURES; CYTOKINES; DOWN-REGULATION; EPITHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; PULMONARY ASPERGILLOSIS; RESPIRATORY MUCOSA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 84936996675     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0333OC     Document Type: Article

References (47)

1. Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev 2009;22:447-465.
2. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32.
3. Cockrill BA, Hales CA. Allergic bronchopulmonary aspergillosis. Annu Rev Med 1999;50:303-316.
4. Chazalet V, Debeaupuis JP, Sarfati J, Lortholary J, Ribaud P, Shah P, Cornet M, Vu Thien H, Gluckman E, Brücker G, et al. Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Microbiol 1998;36:1494-1500.
5. Hogaboam CM, Carpenter KJ, Schuh JM, Buckland KF. Aspergillus and asthma: any link? Med Mycol 2005;43:S197-S202.
6. Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 2002;168:5278-5286.
7. Ochkur SI, Jacobsen EA, Protheroe CA, Biechele TL, Pero RS, McGarry MP, Wang H, O'Neill KR, Colbert DC, Colby TV, et al. Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J Immunol 2007;178:7879-7889.
8. Chaplin DD. Overview of the human immune response. J Allergy Clin Immunol 2006;117(Suppl):S430-S435.
9. Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol 2006;177:5186-5194.
10. Allard JB, Rinaldi L, Wargo MJ, Allen G, Akira S, Uematsu S, Poynter ME, Hogan DA, Rincon M, Whittaker LA. Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products. Eur J Immunol 2009;39:776-788.
11. Steele C, Rapaka RR, Metz A, Pop SM, Williams DL, Gordon S, Kolls JK, Brown GD. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 2005;1:e42.
12. Ricks DM, Chen K, Zheng M, Steele C, Kolls JK. Dectin immunoadhesins and pneumocystis pneumonia. Infect Immun 2013;81:3451-3462.
13. Schleimer RP, Kato A, Peters A, Conley D, Kim J, Liu MC, Harris KE, Kuperman DA, Chandra R, Favoreto S Jr, et al. Epithelium, inflammation, and immunity in the upper airways of humans: studies in chronic rhinosinusitis. Proc Am Thorac Soc 2009;6:288-294.
14. Schleimer RP, Kato A, Kern R, Kuperman D, Avila PC. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 2007;120:1279-1284.
15. Kato A, Schleimer RP. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr Opin Immunol 2007;19:711-720.
16. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 2004;31:358-364.
17. Wada K, Kobayashi T, Matsuwaki Y, Moriyama H, Kita H. Alternaria inhibits double-stranded RNA-induced cytokine production through Toll-like receptor 3. Int Arch Allergy Immunol 2013;161:75-83.
18. Kato A, Truong-Tran AQ, Scott AL, Matsumoto K, Schleimer RP. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol 2006;177:7164-7172.
19. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002;168:3195-3204.
20. Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P. Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000;105:1185-1193.
21. Cieslewicz G, Tomkinson A, Adler A, Duez C, Schwarze J, Takeda K, Larson KA, Lee JJ, Irvin CG, Gelfand EW. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest 1999;104:301-308.
22. Shen HH, Ochkur SI, McGarry MP, Crosby JR, Hines EM, Borchers MT, Wang H, Biechelle TL, O'Neill KR, Ansay TL, et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J Immunol 2003;170:3296-3305.
23. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002;34:909-917.
24. Beisswenger C, Hess C, Bals R. Aspergillus fumigatus conidia induce interferon-b signalling in respiratory epithelial cells. Eur Respir J 2012;39:411-418.
25. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 2004;23:327-333.
26. Message SD, Johnston SL. Host defense function of the airway epithelium in health and disease: clinical background. J Leukoc Biol 2004;75:5-17.
27. Zaas AK, Schwartz DA. Innate immunity and the lung: defense at the interface between host and environment. Trends Cardiovasc Med 2005;15:195-202.
28. Balloy V, Sallenave JM, Wu Y, Touqui L, Latgé JP, Si-Tahar M, Chignard M. Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway. J Biol Chem 2008;283:30513-30521.
29. Balloy V, Si-Tahar M, Takeuchi O, Philippe B, Nahori MA, Tanguy M, Huerre M, Akira S, Latgé JP, Chignard M. Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis. Infect Immun 2005;73:5420-5425.
30. Dubourdeau M, Athman R, Balloy V, Huerre M, Chignard M, Philpott DJ, Latgé JP, Ibrahim-Granet O. Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4. J Immunol 2006;177:3994-4001.
31. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002;277:39320-39326.
32. Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 2004;114:997-1008, quiz 1009.
33. Netea MG, Ferwerda G, van der Graaf CA, Van der Meer JW, Kullberg BJ. Recognition of fungal pathogens by toll-like receptors. Curr Pharm Des 2006;12:4195-4201.
34. Hess C, Herr C, Beisswenger C, Zakharkina T, Schmid RM, Bals R. Myeloid RelA regulates pulmonary host defense networks. Eur Respir J 2010;35:343-352.
35. Zhu L, Lee B, Zhao F, Zhou X, Chin V, Ling SC, Chen Y. Modulation of airway epithelial antiviral immunity by fungal exposure. Am J Respir Cell Mol Biol 2014;50:1136-1143.
36. Abad A, Fernández-Molina JV, Bikandi J, Ramírez A, Margareto J, Sendino J, Hernando FL, Pontón J, Garaizar J, Rementeria A. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol 2010;27:155-182.
37. Le Bon A, Tough DF. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002;14:432-436.
38. Takaoka A, Yanai H. Interferon signalling network in innate defence. Cell Microbiol 2006;8:907-922.
39. Kato A, Ogasawara T, Homma T, Saito H, Matsumoto K. Lipopolysaccharide-binding protein critically regulates lipopolysaccharide-induced IFN-beta signaling pathway in human monocytes. J Immunol 2004;172:6185-6194.
40. Kato A, Homma T, Batchelor J, Hashimoto N, Imai S, Wakiguchi H, Saito H, Matsumoto K. Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol 2003;4:8.
41. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T, Rao G, Sun R, Haberland M, Modlin R, et al. IRF3 mediates a TLR3/ TLR4-specific antiviral gene program. Immunity 2002;17:251-263.
42. Moynagh PN. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol 2005;26:469-476.
43. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005;5:375-386.
44. Decker T, Müller M, Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 2005;5:675-687.
45. Rakes GP, Arruda E, Ingram JM, Hoover GE, Zambrano JC, Hayden FG, Platts-Mills TA, Heymann PW. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care: IgE and eosinophil analyses. Am J Respir Crit Care Med 1999;159:785-790.
46. Chai LY, van de Veerdonk F, Marijnissen RJ, Cheng SC, Khoo AL, Hectors M, Lagrou K, Vonk AG, Maertens J, Joosten LA, et al. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 2010;130:46-54.
47. Hallstrand TS, Woodruff PG, Holgate ST, Knight DA. Function of the airway epithelium in asthma. J Allergy (Cairo) 2012;2012:160586.